Cerity Partners LLC cut its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 26.3% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 36,884 shares of the company's stock after selling 13,176 shares during the quarter. Cerity Partners LLC's holdings in Acadia Healthcare were worth $1,118,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also modified their holdings of the company. Brown Advisory Inc. acquired a new position in Acadia Healthcare during the 1st quarter worth $25,125,000. Envestnet Asset Management Inc. grew its stake in Acadia Healthcare by 8.2% during the 1st quarter. Envestnet Asset Management Inc. now owns 108,238 shares of the company's stock worth $3,282,000 after purchasing an additional 8,222 shares in the last quarter. Palisade Capital Management LP grew its stake in Acadia Healthcare by 2.1% during the 1st quarter. Palisade Capital Management LP now owns 613,332 shares of the company's stock worth $18,596,000 after purchasing an additional 12,807 shares in the last quarter. Teacher Retirement System of Texas acquired a new position in Acadia Healthcare during the 1st quarter worth $412,000. Finally, Envestnet Portfolio Solutions Inc. acquired a new position in Acadia Healthcare during the 1st quarter worth $222,000.
Acadia Healthcare Stock Performance
Shares of Acadia Healthcare stock traded up $0.51 on Friday, hitting $22.25. The stock had a trading volume of 1,451,367 shares, compared to its average volume of 1,692,284. The company's 50 day moving average price is $22.68 and its 200 day moving average price is $29.38. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.72. The stock has a market cap of $2.05 billion, a price-to-earnings ratio of 10.96, a P/E/G ratio of 4.24 and a beta of 0.93. Acadia Healthcare Company, Inc. has a 52-week low of $20.35 and a 52-week high of $82.40.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its quarterly earnings data on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, topping analysts' consensus estimates of $0.35 by $0.05. Acadia Healthcare had a return on equity of 8.72% and a net margin of 5.94%. The company had revenue of $770.51 million during the quarter, compared to analysts' expectations of $769.90 million. During the same period last year, the firm earned $0.84 EPS. The firm's revenue for the quarter was up .3% on a year-over-year basis. On average, research analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.
Analysts Set New Price Targets
Several research analysts have recently issued reports on ACHC shares. Mizuho lowered their price objective on Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating for the company in a research report on Wednesday, May 14th. KeyCorp lowered their price objective on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating for the company in a research report on Wednesday, May 14th. Barclays lowered their price objective on Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating for the company in a research report on Wednesday, May 14th. Wall Street Zen cut Acadia Healthcare from a "hold" rating to a "sell" rating in a research report on Saturday. Finally, Stephens raised Acadia Healthcare to a "hold" rating in a research report on Monday, June 2nd. One research analyst has rated the stock with a sell rating, four have given a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, Acadia Healthcare has an average rating of "Hold" and an average price target of $47.94.
Read Our Latest Report on ACHC
Acadia Healthcare Company Profile
(
Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Further Reading
Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access